Paper · 7954792

The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.

Schwob E and 3 others. Cell, 1994. Cited by 819 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae. Papers, record 7954792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7954792

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae.; PubMed
Journal: Cell; PubMed
Year: 1994; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7954792/; PubMed
DOI: https://doi.org/10.1016/0092-8674(94)90193-7; PubMed
The journal: https://conductscience.org/library/journal-index/0413066; PubMed
Citations, by iCite: 819; iCite
Relative citation ratio, by iCite: 13; iCite
Revised in PubMed: 2019-07-05; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Schwob E	E
2	Böhm T	T
3	Mendenhall MD	M D
4	Nasmyth K	K

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
CDC28 Protein Kinase, S cerevisiae	Major topic
Cell Cycle	Major topic
Cyclin B	Major topic
Cyclins	Major topic
Fungal Proteins	Major topic
Saccharomyces cerevisiae	Major topic
Saccharomyces cerevisiae Proteins	Major topic
Ubiquitin-Protein Ligase Complexes	Major topic
Anaphase-Promoting Complex-Cyclosome
Cyclin-Dependent Kinase Inhibitor Proteins
Ligases
Ubiquitin-Conjugating Enzymes
Ubiquitin-Protein Ligases

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

Kind	PMID	Title	In Papers
Comment in	7,954,786	Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle.	https://conductscience.org/library/papers/7954786

Source PubMed

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by396

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 819 citations.

PMID	Title	Journal	Year	In Papers	Source
42,782,438	Evolution of the Cell-Cycle Clock Models: Biochemical or Transcriptional?	Adv Exp Med Biol	2026	https://conductscience.org/library/papers/42782438	PubMed
42,321,248	A cyclin-polarity feedback network ensures healthy cell proliferation.	Nat Commun	2026	https://conductscience.org/library/papers/42321248	PubMed
42,282,035	Chromatin architecture sets origin licensing capacity.	Res Sq	2026	https://conductscience.org/library/papers/42282035	PubMed
42,244,596	Chromatin architecture sets origin licensing capacity.	bioRxiv	2026	https://conductscience.org/library/papers/42244596	PubMed
41,706,863	Tuning of the RBR1-E2F/DP transcriptional module by the F-box protein FBL17.	Sci Adv	2026	https://conductscience.org/library/papers/41706863	PubMed
41,665,005	sic1 mutation leads to rDNA instability by partial duplication with SIR4.	Nucleic Acids Res	2026	https://conductscience.org/library/papers/41665005	PubMed
40,750,925	How multispecific molecules are transforming pharmacotherapy.	Nat Rev Drug Discov	2025	https://conductscience.org/library/papers/40750925	PubMed
40,546,943	Loss of G1-phase CDK-inhibition biases instability between genomic regions by unevenly reducing activity among replication origins.	iScience	2025	https://conductscience.org/library/papers/40546943	PubMed
39,018,246	Proteomic analysis reveals a PLK1-dependent G2/M degradation program and a role for AKAP2 in coordinating the mitotic cytoskeleton.	Cell Rep	2024	https://conductscience.org/library/papers/39018246	PubMed
38,452,761	Proteome-scale movements and compartment connectivity during the eukaryotic cell cycle.	Cell	2024	https://conductscience.org/library/papers/38452761	PubMed

1 to 10 of 396

See all 396 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
CCNL2	81,669	PubTator's text mining	https://conductscience.org/library/genes/81669

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7954792

GET https://conductscience.org/api/papers/v1/7954792/cited_by?page=2

API reference For AI assistants